Literature DB >> 26181718

Parental education and the WHO neonatal G-6-PD screening program: a quarter century later.

M Kaplan1, C Hammerman1,2, V K Bhutani3.   

Abstract

Neonatal screening for glucose-6-phosphate dehydrogenase (G-6-PD) deficiency in any population with a male frequency >3-5%, combined with parental education regarding the dietary, environmental and sepsis-related triggers for hemolysis was recommended by the WHO (World Health Organization) Working Group in 1989. As the aim of identifying G-6-PD deficiency in the newborn period is to avert or detect extreme hyperbilirubinemia developing at home, before the development of kernicterus, the parental role in identifying evolving icterus was considered integral to any screening program. Now, a quarter century after publication of this report, severe bilirubin neurotoxicity associated with G-6-PD deficiency continues to be encountered worldwide. Screening programs have not been universally introduced but several national or regional maternal child health programs have implemented neonatal G-6-PD screening. Some reports detail the role of parental education, based on the above mentioned principles, through a variety of audio-visual materials. The paucity of randomized controlled trials or validated evidence to demonstrate the effectiveness of the contribution of parental education fails to meet the ideal testable evidence-based approach. However, our review of the cumulative experience and evidence currently available does supply certain information reflecting a positive impact of screening programs combined with parental input. We propose that the current information is sufficient to continue to support and apply the Working Group's recommendations. In order not to waste unnecessary time available, data may be used in lieu of randomized trials to continue to recommend screening programs, as suggested, in high-risk regions. If the incidence of kernicterus associated with G-6-PD deficiency is to be diminished, G-6-PD screening in combination with parental explanation may be one instance in which the consensus approach suggested by the WHO Working Group, rather than reliance on (nonexistent) evidence-based studies, should continue to be practiced.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26181718     DOI: 10.1038/jp.2015.77

Source DB:  PubMed          Journal:  J Perinatol        ISSN: 0743-8346            Impact factor:   2.521


  45 in total

1.  Screening for glucose-6-phosphate dehydrogenase deficiency.

Authors:  M Kaplan; A Abramov; C Hammerman
Journal:  J Pediatr       Date:  1992-07       Impact factor: 4.406

2.  Newborn screening in the Asia Pacific region.

Authors:  Carmencita D Padilla; Bradford L Therrell
Journal:  J Inherit Metab Dis       Date:  2007-07-23       Impact factor: 4.982

3.  Marked decline of favism after neonatal glucose-6-phosphate dehydrogenase screening and health education: the northern Sardinian experience.

Authors:  T Meloni; G Forteleoni; G F Meloni
Journal:  Acta Haematol       Date:  1992       Impact factor: 2.195

4.  The need for neonatal glucose-6-phosphate dehydrogenase screening: a global perspective.

Authors:  M Kaplan; C Hammerman
Journal:  J Perinatol       Date:  2009-02       Impact factor: 2.521

Review 5.  The global prevalence of glucose-6-phosphate dehydrogenase deficiency: a systematic review and meta-analysis.

Authors:  Ella T Nkhoma; Charles Poole; Vani Vannappagari; Susan A Hall; Ernest Beutler
Journal:  Blood Cells Mol Dis       Date:  2009-02-23       Impact factor: 3.039

6.  Mass newborn screening in Singapore--position and projections.

Authors:  R Joseph
Journal:  Ann Acad Med Singapore       Date:  2003-05       Impact factor: 2.473

7.  Screening for glucose-6-phosphate dehydrogenase deficiency can prevent severe neonatal jaundice.

Authors:  A A Mallouh; G Imseeh; Y K Abu-Osba; J A Hamdan
Journal:  Ann Trop Paediatr       Date:  1992

8.  Predictive ability of a predischarge hour-specific serum bilirubin for subsequent significant hyperbilirubinemia in healthy term and near-term newborns.

Authors:  V K Bhutani; L Johnson; E M Sivieri
Journal:  Pediatrics       Date:  1999-01       Impact factor: 7.124

Review 9.  G6PD deficiency in Latin America: systematic review on prevalence and variants.

Authors:  Wuelton M Monteiro; Fernando F A Val; André M Siqueira; Gabriel P Franca; Vanderson S Sampaio; Gisely C Melo; Anne C G Almeida; Marcelo A M Brito; Henry M Peixoto; Douglas Fuller; Quique Bassat; Gustavo A S Romero; Oliveira Maria Regina F; Lacerda Marcus Vinícius G
Journal:  Mem Inst Oswaldo Cruz       Date:  2014-08-19       Impact factor: 2.743

10.  Pattern and predictors of maternal care-seeking practices for severe neonatal jaundice in Nigeria: a multi-centre survey.

Authors:  Chinyere V Ezeaka; Rosemary O Ugwu; Mariya Mukhtar-Yola; Ekanem N Ekure; Bolajoko O Olusanya
Journal:  BMC Health Serv Res       Date:  2014-04-28       Impact factor: 2.655

View more
  7 in total

1.  The African-American neonate at risk for extreme hyperbilirubinemia: a better management strategy is needed.

Authors:  W C Golden
Journal:  J Perinatol       Date:  2017-04       Impact factor: 2.521

2.  Molecular Characterization and Genotype-Phenotype Correlation of G6PD Mutations in Five Ethnicities of Northern Vietnam.

Authors:  Thi Thao Ngo; Thinh Huy Tran; Thanh Dat Ta; Thi Phuong Le; Phuoc Dung Nguyen; Mai Anh Tran; The-Hung Bui; Thanh Van Ta; Van Khanh Tran
Journal:  Anemia       Date:  2022-07-05

3.  Point-of-Care Quantitative Measure of Glucose-6-Phosphate Dehydrogenase Enzyme Deficiency.

Authors:  Vinod K Bhutani; Michael Kaplan; Bertil Glader; Michael Cotten; Jairus Kleinert; Vamsee Pamula
Journal:  Pediatrics       Date:  2015-10-12       Impact factor: 7.124

4.  A novel point-of-care device for measuring glucose-6-phosphate dehydrogenase enzyme deficiency.

Authors:  Ronald J Wong; Cynthia Montiel; Megana Kunda; David K Stevenson; Vinod K Bhutani
Journal:  Semin Perinatol       Date:  2020-12-01       Impact factor: 3.300

5.  A rare disorder or not? How a child with jaundice changed a nationwide regimen in the Netherlands.

Authors:  E A L van den Heuvel; A Baauw; S J Mensink-Dillingh; M Bartels
Journal:  J Community Genet       Date:  2017-09-15

6.  Diagnostic performances of the fluorescent spot test for G6PD deficiency in newborns along the Thailand-Myanmar border: A cohort study.

Authors:  Laurence Thielemans; Gornpan Gornsawun; Borimas Hanboonkunupakarn; Moo Kho Paw; Pen Porn; Paw Khu Moo; Bart Van Overmeire; Stephane Proux; François Nosten; Rose McGready; Verena I Carrara; Germana Bancone
Journal:  Wellcome Open Res       Date:  2018-01-02

7.  Indirect neonatal hyperbilirubinemia in hospitalized neonates on the Thai-Myanmar border: a review of neonatal medical records from 2009 to 2014.

Authors:  L Thielemans; M Trip-Hoving; J Landier; C Turner; T J Prins; E M N Wouda; B Hanboonkunupakarn; C Po; C Beau; M Mu; T Hannay; F Nosten; B Van Overmeire; R McGready; V I Carrara
Journal:  BMC Pediatr       Date:  2018-06-12       Impact factor: 2.125

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.